SDP presents 5-Formamido-1-[2-(formyloxy)ethyl]pyrazole as a specialized pharmaceutical intermediate used in the synthesis of Cefoselis. Also known as 2-(5-formamidopyrazol-1-yl)ethyl formate, this compound is a substituted pyrazole derivative containing formamido and formate ester functional groups.
This intermediate is associated with the synthesis of Cefoselis, a fourth-generation cephalosporin antibacterial agent. Its protected pyrazole structure is used during the preparation of the characteristic pyrazolium-containing side-chain portion of the Cefoselis molecule.
Product Name: 5-Formamido-1-[2-(formyloxy)ethyl]pyrazole
Common Name: Cefoselis Side Chain Intermediate
CAS Number: 116856-18-9
Molecular Formula: C₇H₉N₃O₃
Molecular Weight: 183.17 g/mol
Product Category: Pharmaceutical Intermediate
Application: Cefoselis synthesis
| Parameter | Details |
|---|---|
| Chemical name | 5-Formamido-1-[2-(formyloxy)ethyl]pyrazole |
| IUPAC name | 2-(5-formamidopyrazol-1-yl)ethyl formate |
| CAS number | 116856-18-9 |
| Molecular formula | C₇H₉N₃O₃ |
| Molecular weight | 183.17 g/mol |
| Molecular structure | Substituted pyrazole derivative |
| Functional groups | Formamido group and formate ester |
| Product type | Pharmaceutical intermediate |
| Related API | Cefoselis |
5-Formamido-1-[2-(formyloxy)ethyl]pyrazole is identified as a side-chain intermediate in Cefoselis synthesis. It provides a protected pyrazole building block for the preparation of the pyrazole-containing portion of the antibiotic molecule.
The compound may be used in process-development activities involving pyrazole derivatives and cephalosporin intermediates, subject to the requirements of the relevant synthesis route.
Potential applications include:
Cefoselis is a cephalosporin antibacterial agent. The synthesis route described in patent-related literature uses a formyl-protected hydroxyethyl pyrazole intermediate in the preparation of the pyrazolium-containing cephem structure.
The formamido and formate ester groups are part of the protected intermediate structure. Subsequent synthesis steps transform the protected intermediate into the required substituted pyrazole portion of the Cefoselis molecule.
The exact reaction sequence, reagents, process conditions and impurity profile depend on the selected manufacturing route and validated process.
| Property | Reported information |
|---|---|
| Appearance | White to almost white or pale-yellow crystalline powder; confirm batch appearance |
| Molecular formula | C₇H₉N₃O₃ |
| Molecular weight | 183.17 g/mol |
| CAS number | 116856-18-9 |
| Melting point | Approximately 84–88°C, depending on source and material |
| Solubility | Confirm using product-specific analytical data |
| Chemical nature | Formamido-substituted pyrazole ester |
Reported physical properties are reference information and should not be treated as approved batch-release limits without verification against the supplier's specification and Certificate of Analysis.
Quality evaluation of 5-Formamido-1-[2-(formyloxy)ethyl]pyrazole may include:
Analytical methods and acceptance criteria should be established and approved for the intended manufacturing process. HPLC or GC purity values reported by research-chemical vendors are not automatically applicable as commercial manufacturing specifications.
Batch-specific documentation should be reviewed before material approval.
Packaging should protect the material from contamination, moisture and unsuitable environmental exposure.
Recommended handling principles:
The final packaging configuration and storage conditions should be confirmed from validated stability information and the batch documentation.
This compound is a chemical intermediate intended for controlled industrial, laboratory or pharmaceutical manufacturing use. It is not a finished medicine.
Recommended precautions:
No patient-use or dosage information applies to this raw material.
1. What is 5-Formamido-1-[2-(formyloxy)ethyl]pyrazole?
It is a substituted pyrazole pharmaceutical intermediate used as a side-chain building block in Cefoselis synthesis.
2. What is the CAS number?
The CAS number is 116856-18-9.
3. What is its molecular formula?
Its molecular formula is C₇H₉N₃O₃.
4. What is its molecular weight?
Its molecular weight is approximately 183.17 g/mol.
5. Is this product a Cefoselis API?
No. It is a pharmaceutical intermediate used in Cefoselis synthesis, not the finished Cefoselis API.
6. What is its reported melting point?
Published supplier references report a melting range around 84–88°C. The actual acceptance range should be confirmed against the approved product specification.
7. Is the product suitable for pharmaceutical manufacturing?
Suitability depends on the customer's process requirements, approved specification, analytical results and quality documentation.
8. Which analytical documents should be requested?
A batch-specific Certificate of Analysis and Safety Data Sheet should be requested. Additional analytical and quality documents may be required by the customer's qualification procedure.
For product information, specifications, analytical documentation, packaging details and commercial enquiries regarding 5-Formamido-1-[2-(formyloxy)ethyl]pyrazole, contact SDP.
SDP – Pharmaceutical Intermediates and Specialty Chemicals
Please share your required quantity, target specification, intended application and documentation requirements to support your enquiry.
| Parameter | Specification |
|---|---|
| Appearance | White to almost white |
| Identification | IR and HPLC complaint |
| Assay (HPLC) | 98.5–101.0% |
| Loss on Drying | NMT 6.0% |
| Residue on Ignition | NMT 0.2% |
| Heavy Metals | NMT 10 ppm |
| Solubility | Slightly soluble in water |